{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:51:53Z","timestamp":1777431113759,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>With an increasing prevalence, peripheral arterial disease (PAD), cause by atherosclerosis is a new threat to public health beyond coronary artery disease and involves aberrant vascular endothelial cell proliferation and angiogenesis. The degree of vascular remodeling is influenced by the processes described. MicroRNA-21 (miR-21) has been found to play a critical role in cellular functions, including angiogenesis. Nevertheless, the effect of miR-21 on endothelial cells in response to hypoxia is largely unknown. Using wild-type C57BL\/6J and miR-21<jats:sup>\u2013\/\u2013<\/jats:sup> mice, we compared the capability of angiogenesis in response to hindlimb hypoxic\/ischemia. <jats:italic>In an in vitro<\/jats:italic> study, we further studied whether overexpression of miR-21 mitigates hypoxia-induced apoptosis and impaired angiogenesis. Also, we prospectively collected the sera of patients with limb ischemia and followed the clinical information, including major adverse limb events (MALEs). Using laser Doppler perfusion imaging and CD31 staining, compared with miR-21<jats:sup>\u2013\/\u2013<\/jats:sup> mice, wild-type mice expressed a significantly higher capability of angiogenesis and less apoptosis following 28 days of hindlimb hypoxic\/ischemic surgery. In our <jats:italic>in vitro<\/jats:italic> study, after 24 h of hypoxia, proliferation, migration, and tube formation were significantly impaired in cells treated with the miR-21 inhibitor but rescued by the miR-21 mimic. Mechanistically, by suppressing PTEN\/PI3K\/AKT, miR-21 promoted angiogenesis and suppressed apoptosis in endothelial cells post hypoxia. In patients with limb ischemia, the high expression of circulating miR-21 was associated with less subsequent MALE. Collectively, miR-21 could be a biomarker associated with the endogenous ability of angiogenesis and reflect subsequent MALE in patients. Additionally, abolishing miR-21 impairs angiogenesis and promotes apoptosis post limb ischemia. Further studies are required to elucidate the clinical applications of miR-21.<\/jats:p>","DOI":"10.3389\/fcvm.2022.826478","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T05:46:47Z","timestamp":1650952007000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Deletion of MicroRNA-21 Impairs Neovascularization Following Limb Ischemia: From Bedside to Bench"],"prefix":"10.3389","volume":"9","author":[{"given":"Wei-Ting","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Sen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ya","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Hsing","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhih-Cherng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhih-Yuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chon-Seng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/circresaha.116.303503","article-title":"Endovascular intervention for peripheral artery disease.","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1526602815574687","article-title":"A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.","volume":"22","author":"Tangelder","year":"2015","journal-title":"J Endovasc Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/0003319714551361","article-title":"Effect of cilostazol following endovascular intervention for peripheral artery disease.","volume":"66","author":"Nanto","year":"2015","journal-title":"Angiology."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization.","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2018.02.011","article-title":"Angiogenesis in peripheral arterial disease.","volume":"39","author":"Inampudi","year":"2018","journal-title":"Curr Opin Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/ATVBAHA.120.312862","article-title":"Vascular regeneration in peripheral artery disease.","volume":"40","author":"Cooke","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside.","volume":"15","author":"Ratti","year":"2020","journal-title":"Target Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol Sin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3892\/mmr.2012.978","article-title":"Role of microRNAs in peripheral artery disease (review).","volume":"6","author":"Zhou","year":"2012","journal-title":"Mol Med Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1158\/1078-0432.CCR-08-3257","article-title":"Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.","volume":"15","author":"Yamamichi","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/path.4295","article-title":"miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis.","volume":"232","author":"Hsu","year":"2014","journal-title":"J Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.31557\/APJCP.2020.21.10.2817","article-title":"The expression of MicroRNA-21 in bone marrow fluid is an indicator of hematological disorders and mortality.","volume":"21","author":"Chang","year":"2020","journal-title":"Asian Pac J Cancer Prev."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107886","article-title":"Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K\/Akt\/VEGF signaling pathway in diabetic retinopathy.","volume":"190","author":"Lu","year":"2020","journal-title":"Exp Eye Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1101\/gad.1308805","article-title":"The PTEN\/PI3K pathway governs normal vascular development and tumor angiogenesis.","volume":"19","author":"Hamada","year":"2005","journal-title":"Genes Dev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cvr\/cvn325","article-title":"Phosphoinositide 3-kinase signalling in the vascular system.","volume":"82","author":"Morello","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mvr.2016.12.006","article-title":"Impacts of femoral artery and vein excision versus femoral artery excision on the hindlimb ischemic model in CD-1 mice.","volume":"110","author":"Chen","year":"2017","journal-title":"Microvasc Res."},{"key":"B19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jacc.2009.08.090","article-title":"Biomarkers of peripheral arterial disease.","volume":"55","author":"Cooke","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/circgenetics.111.000053","article-title":"Differential microRNA expression profiles in peripheral arterial disease.","volume":"6","author":"Stather","year":"2013","journal-title":"Circ Cardiovasc Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.vph.2011.06.006","article-title":"MicroRNA regulation in angiogenesis.","volume":"55","author":"Caporali","year":"2011","journal-title":"Vascul Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00790","article-title":"miR-21 protects against ischemia\/reperfusion-induced acute kidney injury by preventing epithelial cell apoptosis and inhibiting dendritic cell maturation.","volume":"9","author":"Song","year":"2018","journal-title":"Front Physiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0805-5","article-title":"MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7.","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/stem.2321","article-title":"Human stem cells overexpressing miR-21 promote angiogenesis in critical limb ischemia by targeting CHIP to enhance HIF-1\u03b1 activity.","volume":"34","author":"Zhou","year":"2016","journal-title":"Stem Cells."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia.","volume":"27","author":"Kulshreshtha","year":"2007","journal-title":"Mol Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2015-z","article-title":"miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis.","volume":"17","author":"Du","year":"2019","journal-title":"J Transl Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016979","article-title":"MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells.","volume":"6","author":"Sabatel","year":"2011","journal-title":"PLoS One."},{"key":"B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbrc.2010.02.045","article-title":"MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity.","volume":"393","author":"Weber","year":"2010","journal-title":"Biochem Biophys Res Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jvs.2005.08.042","article-title":"Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia.","volume":"43","author":"Ho","year":"2006","journal-title":"J Vasc Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2013.05.022","article-title":"Hypoxia: a master regulator of microRNA biogenesis and activity.","volume":"64","author":"Nallamshetty","year":"2013","journal-title":"Free Radic Biol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1128\/MCB.01276-10","article-title":"MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia.","volume":"31","author":"Bruning","year":"2011","journal-title":"Mol Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/MCB.01242-10","article-title":"A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like.","volume":"31","author":"Kelly","year":"2011","journal-title":"Mol Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.febslet.2014.05.067","article-title":"A feedback regulatory loop between HIF-1\u03b1 and miR-21 in response to hypoxia in cardiomyocytes.","volume":"588","author":"Liu","year":"2014","journal-title":"FEBS Lett."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160589","article-title":"Plasma miR-21 expression: an indicator for the severity of Type 2 diabetes with diabetic retinopathy.","volume":"37","author":"Jiang","year":"2017","journal-title":"Biosci Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.biopha.2018.05.157","article-title":"Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma.","volume":"105","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121547","article-title":"Modulation of NF-\u03baB\/miR-21\/PTEN pathway sensitizes non-small cell lung cancer to cisplatin.","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6020040","article-title":"Roles of NF-\u03baB signaling in the regulation of miRNAs impacting on inflammation in cancer.","volume":"6","author":"Markopoulos","year":"2018","journal-title":"Biomedicines."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1161\/01.atv.20.11.e83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function.","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-37","article-title":"VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K\/Akt-NF-kappaB signaling pathway.","volume":"7","author":"Tong","year":"2006","journal-title":"Respir Res."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0636-9","article-title":"Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cells.","volume":"8","author":"You","year":"2017","journal-title":"Stem Cell Res Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/CIRCRESAHA.121.318266","article-title":"New directions in therapeutic angiogenesis and arteriogenesis in peripheral arterial disease.","volume":"128","author":"Annex","year":"2021","journal-title":"Circ Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/ATVBAHA.115.305775","article-title":"Mechanisms of amplified arteriogenesis in collateral artery segments exposed to reversed flow direction.","volume":"35","author":"Heuslein","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacbts.2021.04.008","article-title":"Macrophage polarization as a novel therapeutic target for endovascular intervention in peripheral artery disease.","volume":"6","author":"Tan","year":"2021","journal-title":"JACC Basic Transl Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ymthe.2022.01.008","article-title":"Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease.","volume":"30","author":"Miyake","year":"2022","journal-title":"Mol Ther."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.826478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T05:46:52Z","timestamp":1650952012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.826478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":46,"alternative-id":["10.3389\/fcvm.2022.826478"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.826478","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"826478"}}